Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors
- 1 December 2002
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (6) , 831-836
- https://doi.org/10.1016/s0168-8278(02)00301-x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Factors influencing ribavirin-induced hemolysisJournal of Hepatology, 2001
- Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patientsLiver International, 1999
- In Vivo and In Vitro Induction of MxA Protein in Peripheral Blood Mononuclear Cells from Patients Chronically Infected with Hepatitis C VirusThe Journal of Infectious Diseases, 1999
- Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C: Results of a multicenter randomized trialJournal of Hepatology, 1997
- Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis CHepatology, 1997
- A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis CJournal of Hepatology, 1996
- Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosisHepatology, 1995
- THE PREDICTIVE VALUE OF DONOR LIVER BIOPSIES FOR THE DEVELOPMENT OF PRIMARY NONFUNCTION AFTER ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989